Tag: UK

Brexit, Regulatory Update

ACUTA RIM Shots – August 16 Special Brexit Edition

Lots of Brexit-oriented news in recent days that affects the biotech industry. UK/EMA Separation Implementation Period First of all, in March, the EU and UK agreed to an ‘implementation period’ for medicines to give a little more time for the European Medicines Agency (EMA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA) to¬† …

Brexit, EMA

Can the UK stay in the EMA post-Brexit?

On July 17, 2018, the UK Parliament voted to remain in the European Medicines Agency (EMA) after Britain withdraws from the European Union (“Brexit”). This is not a done deal: the vote only means that the UK government must negotiate to continue to participate in the EMA. This will probably involve negotiating an appropriate payment …